Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 521, pseudogene (RN7SL521P) is classified as a pseudogene derived from the 7SL RNA gene family. 7SL RNA is normally an essential component of the signal recognition particle (SRP), which is involved in targeting proteins to the endoplasmic reticulum in eukaryotic cells. However, the majority of 7SL-like sequences in the human genome are considered pseudogenes, having lost their original function—these arise through reverse transcription of 7SL RNA and re-integration into the genome, often as truncated, nonfunctional copies. RN7SL521P is one such nonfunctional copy and does not encode a protein or functional RNA, nor does it have a recognized role in cellular signaling, disease, or as a drug target. While some transcribed pseudogenes can have regulatory functions (e.g., as competing endogenous RNAs or miRNA sponges), the majority—including RN7SL521P—show no evidence of such roles. They are predominantly considered "genomic fossils" with no established physiological or therapeutic significance. Key point: This is not a therapeutic target, nor a functional gene—it is a nonfunctional pseudogene associated with the 7SL RNA family. Notes on correctness: - RN7SL521P is accurately named and classified, but it is not a therapeutic target (e.g., receptor, enzyme, transporter) nor does it have a known biological or disease role. - If seeking biological targets for research or drug discovery, this is likely an incorrect or irrelevant entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 521, pseudogene (RN7SL521P).